ProText Mobility (TXTM) AI Stock Analysis

ProText Mobility

(Other OTC:TXTM)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Negative Factors

ProText Mobility (TXTM) vs. SPDR S&P 500 ETF (SPY)

Not enough price history over this period.

Market Cap: $70.33M
Dividend Yield: ―
Average Volume (3M): 17.67M
Price to Earnings (P/E): 80.0
Beta (1Y): 1.47
Revenue Growth: ―
EPS Growth: ―
Country: US
Employees: 30
Sector: General
Sector Strength: 55
Industry: Biotechnology

ProText Mobility Business Overview & Revenue Model

Company Description

ProText Mobility, Inc., a biotech company, engages in the development of pharmaceutical botanical medicines. Its medicines are formulated with highly-bioavailable plant extracts. The company is based in Fort Lauderdale, Florida.

ProText Mobility Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

TXTM against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
INM	48Neutral	$8.79M	-0.46	-134.73%	―	-60.74%	66.05%
MOVE	43Neutral	$210.77M	-0.55	-9.67%	―	843.62%	21.98%
KALA	39Underperform	$3.20M	-0.00	-222.32%	―	―	78.25%

* General Sector Average

Performance Comparison

TXTM and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TXTM	ProText Mobility	―	―	―
INM	Inmed Pharmaceuticals Inc.	1.60	-0.25	-13.51%
KALA	Kala Bio, Inc.	0.17	-37.92	-99.57%
MOVE	Corvex, Inc.	6.68	2.59	63.49%
SPRC	SciSparc Ltd.	0.68	-29.20	-97.74%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

ProText Mobility AI Stock Analysis